EV/EBITDA Ratio: 45.55x

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 45.55x is in line with its estimated 5-year average of 42.55x, near the low end of its estimated 5-year range (7.53x–6316.95x).

As of 2026-10-06T15:47:17.793Z. 24.27% below its estimated 12-month average of 60.15x.

LGND EV/EBITDA Ratio Metrics

EV/EBITDA vs. estimated history

At 45.5, EV/EBITDA is near its estimated 15-year median — higher than 63% of readings in its estimated 15-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The EV/EBITDA ratio for LGND stock is 45.55x.

Is Ligand Pharmaceuticals Incorporated's EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 45.55x is in line with its estimated 5-year average of 42.55x, near the low end of its estimated 5-year range (7.53x–6316.95x).

What is the estimated TTM average EV/EBITDA ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The estimated TTM average EV/EBITDA ratio for LGND stock is 60.15x.

What is the estimated 3Y average EV/EBITDA ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The estimated 3Y average EV/EBITDA ratio for LGND stock is 66.25x.

What is the estimated 5Y average EV/EBITDA ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The estimated 5Y average EV/EBITDA ratio for LGND stock is 42.55x.

What is the estimated 10Y average EV/EBITDA ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The estimated 10Y average EV/EBITDA ratio for LGND stock is 23.49x.

What is the estimated 15Y average EV/EBITDA ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The estimated 15Y average EV/EBITDA ratio for LGND stock is 38.00x.

Showing the most recent 260 of 3,612 data points. The chart above shows the full history.

Related Metrics